ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop 'off the shelf' stem cell treatments, without the need for immunosuppressive drugs. The Company's lead cell therapy candidate is in clinical development for the blindness-causing disease, retinitis pigmentosa.
ReNeuron is also advancing its proprietary exosome technology platform as a potential delivery system for drugs that treat diseases of the brain. he Company also has the ability through its conditionally immortalised induced pluripotent stem cell (iPSC) platform to make any tissue cells of choice; in-house programmes are focused on treatments for blood cancers and diabetes.
https://www.share-talk.com/olav-hellebo-ceo-of-group-plc-rene-l-interview/
https://www.share-talk.com/olav-hellebo-ceo-of-group-plc-rene-l-interview/
Listen On
Also Listen
-
Interview: Capital Metals – Advancing the Taprobane Minerals Project in Sri Lanka
Zak Mir talks to Greg Martyr, Executive Chairman, Capital Metals, in the wake of -
Interview with Jim Mellon: Insights on the 2025 Market Landscape and Investment Strategies
In a recent conversation with renowned investor Jim Mellon, Zak Mir delved deep -
Sam Garrett Chief Executive Officer of Great Southern Copper talking with Andrew Scott
Great Southern Copper plc (LSE: GSCU) continues to make exciting strides at its -
Zak Mir Talks to Howard White, Non-Executive Chairman of Hydrogen Utopia Intl
Zak Mir talks to Howard White, Chairman of Hydrogen Utopia, a company specialisi